AKTS - Aktis Oncology • Profitability
Aktis Oncology, Inc. is a clinical-stage biotechnology company dedicated to transforming the treatment of solid tumors through the development of targeted alpha-emitting radiopharmaceuticals. The company's innovative approach leverages its proprietary platform to create highly potent and selective radioligand therapies designed to deliver alpha radiation directly to cancer cells, minimizing damage to healthy tissues. Aktis Oncology's pipeline is focused on addressing significant unmet needs in oncology, particularly for patients with difficult-to-treat solid tumors. Their lead programs are engineered to target specific tumor antigens, ensuring precise delivery of therapeutic payloads. By utilizing alpha emitters, which have a short path length and high linear energy transfer, Aktis aims to achieve superior tumor killing efficacy compared to traditional beta-emitting radiopharmaceuticals. The company's strategy involves advancing its lead candidates through clinical development, while also expanding its platform to discover new targets and develop next-generation radiopharmaceuticals. Aktis Oncology is positioned within the rapidly evolving field of radiopharmaceutical therapy, seeking to establish itself as a leader in this promising modality for cancer treatment.
100%
Gross Margin
Gross margin measures the amount of revenue that remains after subtracting costs directly associated with production.
—
EBITDA Margin
The EBITDA margin is a measure of a company's operating profit desconsidering D&A costs as a percentage of its revenue.
—
EBIT Margin
The EBIT margin is a measure of a company's operating profit considering D&A costs as a percentage of its revenue.
—
Net Margin
The net profit margin, or simply net margin, measures how much net income or profit is generated as a percentage of revenue. It is the ratio of net profits to revenues for a company or business segment.
0%
D&A/EBITDA
Many companies have a high D&A in relation to the company's operating profit (EBITDA) and although this indicator does not have an effective cash effect, it ends up influencing the accounting net income, so analyzing this relationship can help to understand when D&A has a relevant impact to the company's results.
778,1%
R&D/Revenue
Shows the amount spent on investments in research and development in relation to the Net Revenue for the period. The company can use these investments to try to increase its revenue in the future.
92,2%
Capex/Revenue
Shows the amount spent on investments in Capex in relation to Net Revenue for the period. The company can use these investments to try to increase its revenue in the future.
328,3%
Capex/D&A
Indicates a comparison between investments in fixed/intangible assets and the depreciation and amortization of some company assets. It serves to let managers know that the company's assets are devaluing periodically, and whether CAPEX has followed the same pace or not.
-12,3%
Capex/OCF
It shows the percentage of operating cash flow that the company uses in Capex (investments in fixed and intangible assets). When your result is greater than 100%, it demonstrates that there are expenses greater than what the company produces in its operations.
—
SBC/OCF
It demonstrates the percentage cost of Stock-Based Compensation compared to the company's operating cash flow. In some companies, the OCF is positive because of the SBC, which can lead to an incorrect cash flow analysis.
5,1%
% PPE
If the company has a lot of D&A, it helps to see if most of it tends to come from fixed assets. The account can include machinery, equipment, vehicles, buildings, land, office equipment, and furnishings, among other things.
0%
% Goodwill
If the company has a lot of D&A, it helps to see if most of it tends to come from Goodwill, that is an intangible asset that accounts for the excess purchase price of another company.
—
ROE
Return on equity (ROE) is the measure of a company's net income divided by its shareholders' equity and is a gauge of a corporation's profitability and how efficiently it generates those profits.
—
ROIC
Return on invested capital (ROIC) is a calculation used to assess a company's efficiency in allocating capital to profitable investments. The formula for calculating ROIC involves dividing Net Income by the average of invested capital.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!